Liu Tongming is a Chinese businessman and media/technology investor best known for his involvement in digital content platforms and MCN (multi-channel network) companies in China.
Dr. Tong Ming Liu got his PhD in genetics from Institute of Hydrobiology, The Chinese Academy of Sciences. He then joined the research group of Prof. Eng Hin Lee at National University of Singapore and Prof. Bing Lim at Genome Institute of Singapore to study human mesenchymal stem cells. He has 17 years of independent research in the field of MSCs focusing on gene and cell therapy of human mesenchymal stem cells. He has run multiple national grants as PIs and co-PIs since 2006. He has published 30 research articles, including NCB, Nat Commun, Bioactive Materials, PNAS, Arthritis & Rheumatism, Stem Cell Reports, Stem Cells, Stem Cell Transl Med, Tissue Engineering and Stem Cells Dev etc. He has served as editorial board member of 29 international journals and guest editor of Front. Cell Dev. Biol (IF6.68).
1. Chinese text error correction (2024)
2. Environmental engineering / soil science (2024)
3. Catalysis / materials chemistry (co-author)